Review





Similar Products

primary antibodies against cyclin a2  (Proteintech)
96
Proteintech primary antibodies against cyclin a2
Primary Antibodies Against Cyclin A2, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary antibodies against cyclin a2/product/Proteintech
Average 96 stars, based on 1 article reviews
primary antibodies against cyclin a2 - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier
primary antibodies against cdk6 (3136s), cyclin d1 (2978s), and tubulin (3873s)  (Cell Signaling Technology Inc)
90
Cell Signaling Technology Inc primary antibodies against cdk6 (3136s), cyclin d1 (2978s), and tubulin (3873s)
Primary Antibodies Against Cdk6 (3136s), Cyclin D1 (2978s), And Tubulin (3873s), supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary antibodies against cdk6 (3136s), cyclin d1 (2978s), and tubulin (3873s)/product/Cell Signaling Technology Inc
Average 90 stars, based on 1 article reviews
primary antibodies against cdk6 (3136s), cyclin d1 (2978s), and tubulin (3873s) - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
primary antibody against cyclin b  (Cell Signaling Technology Inc)
90
Cell Signaling Technology Inc primary antibody against cyclin b
Primary Antibody Against Cyclin B, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary antibody against cyclin b/product/Cell Signaling Technology Inc
Average 90 stars, based on 1 article reviews
primary antibody against cyclin b - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
primary antibodies against cyclin d1, myc, α-tublin, and gapdh  (Selleck Chemicals)
90
Selleck Chemicals primary antibodies against cyclin d1, myc, α-tublin, and gapdh
Rosmarinic acid inhibits the expressions of cell proliferative genes. A: HT29 and SW480 cells were incubated with increasing concentrations of rosmarinic acid (RA) for 24 hours, followed by Western blot analysis <t>using</t> <t>antibodies</t> against cyclin D1 and MYC. α-Tublin was used as a loading control; B and C: The above cells were also prepared for quantitative real-time polymerase chain reaction to evaluate the mRNA levels of cyclin A1. <t>GAPDH</t> was used as an internal control; D: HT29 cells were treated with indicated concentrations of RA for 24 hours, followed by Western blot analysis using antibodies against Bcl-2, caspase-3, and GAPDH; E: HT29 cells were treated with indicated concentrations of RA for 24 hours, and then stained with Annexin V-FITC and propidium iodide. Percentages of Annexin V + cells are indicated in the scatterplot (right low and upper quadrants). n = 3. Data are shown as the mean ± SD. a P < 0.0001 vs group ‘0’. RA: Rosmarinic acid; AKT: Protein kinase B.
Primary Antibodies Against Cyclin D1, Myc, α Tublin, And Gapdh, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary antibodies against cyclin d1, myc, α-tublin, and gapdh/product/Selleck Chemicals
Average 90 stars, based on 1 article reviews
primary antibodies against cyclin d1, myc, α-tublin, and gapdh - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
primary antibodies against cyclin-dependent kinase 1  (Thermo Fisher)
90
Thermo Fisher primary antibodies against cyclin-dependent kinase 1
Rosmarinic acid inhibits the expressions of cell proliferative genes. A: HT29 and SW480 cells were incubated with increasing concentrations of rosmarinic acid (RA) for 24 hours, followed by Western blot analysis <t>using</t> <t>antibodies</t> against cyclin D1 and MYC. α-Tublin was used as a loading control; B and C: The above cells were also prepared for quantitative real-time polymerase chain reaction to evaluate the mRNA levels of cyclin A1. <t>GAPDH</t> was used as an internal control; D: HT29 cells were treated with indicated concentrations of RA for 24 hours, followed by Western blot analysis using antibodies against Bcl-2, caspase-3, and GAPDH; E: HT29 cells were treated with indicated concentrations of RA for 24 hours, and then stained with Annexin V-FITC and propidium iodide. Percentages of Annexin V + cells are indicated in the scatterplot (right low and upper quadrants). n = 3. Data are shown as the mean ± SD. a P < 0.0001 vs group ‘0’. RA: Rosmarinic acid; AKT: Protein kinase B.
Primary Antibodies Against Cyclin Dependent Kinase 1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary antibodies against cyclin-dependent kinase 1/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
primary antibodies against cyclin-dependent kinase 1 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
primary antibodies against myod, myogenin, yap, p-yap, taz, tead1, cyclin d1, p53, p21, and gapdh  (Servicebio Inc)
90
Servicebio Inc primary antibodies against myod, myogenin, yap, p-yap, taz, tead1, cyclin d1, p53, p21, and gapdh
Rosmarinic acid inhibits the expressions of cell proliferative genes. A: HT29 and SW480 cells were incubated with increasing concentrations of rosmarinic acid (RA) for 24 hours, followed by Western blot analysis <t>using</t> <t>antibodies</t> against cyclin D1 and MYC. α-Tublin was used as a loading control; B and C: The above cells were also prepared for quantitative real-time polymerase chain reaction to evaluate the mRNA levels of cyclin A1. <t>GAPDH</t> was used as an internal control; D: HT29 cells were treated with indicated concentrations of RA for 24 hours, followed by Western blot analysis using antibodies against Bcl-2, caspase-3, and GAPDH; E: HT29 cells were treated with indicated concentrations of RA for 24 hours, and then stained with Annexin V-FITC and propidium iodide. Percentages of Annexin V + cells are indicated in the scatterplot (right low and upper quadrants). n = 3. Data are shown as the mean ± SD. a P < 0.0001 vs group ‘0’. RA: Rosmarinic acid; AKT: Protein kinase B.
Primary Antibodies Against Myod, Myogenin, Yap, P Yap, Taz, Tead1, Cyclin D1, P53, P21, And Gapdh, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary antibodies against myod, myogenin, yap, p-yap, taz, tead1, cyclin d1, p53, p21, and gapdh/product/Servicebio Inc
Average 90 stars, based on 1 article reviews
primary antibodies against myod, myogenin, yap, p-yap, taz, tead1, cyclin d1, p53, p21, and gapdh - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
primary antibodies against myod, myogenin, yap, p-yap, taz, tead1, cyclin d1, p53, p21, and gapdh  (Proteintech)
90
Proteintech primary antibodies against myod, myogenin, yap, p-yap, taz, tead1, cyclin d1, p53, p21, and gapdh
Rosmarinic acid inhibits the expressions of cell proliferative genes. A: HT29 and SW480 cells were incubated with increasing concentrations of rosmarinic acid (RA) for 24 hours, followed by Western blot analysis <t>using</t> <t>antibodies</t> against cyclin D1 and MYC. α-Tublin was used as a loading control; B and C: The above cells were also prepared for quantitative real-time polymerase chain reaction to evaluate the mRNA levels of cyclin A1. <t>GAPDH</t> was used as an internal control; D: HT29 cells were treated with indicated concentrations of RA for 24 hours, followed by Western blot analysis using antibodies against Bcl-2, caspase-3, and GAPDH; E: HT29 cells were treated with indicated concentrations of RA for 24 hours, and then stained with Annexin V-FITC and propidium iodide. Percentages of Annexin V + cells are indicated in the scatterplot (right low and upper quadrants). n = 3. Data are shown as the mean ± SD. a P < 0.0001 vs group ‘0’. RA: Rosmarinic acid; AKT: Protein kinase B.
Primary Antibodies Against Myod, Myogenin, Yap, P Yap, Taz, Tead1, Cyclin D1, P53, P21, And Gapdh, supplied by Proteintech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary antibodies against myod, myogenin, yap, p-yap, taz, tead1, cyclin d1, p53, p21, and gapdh/product/Proteintech
Average 90 stars, based on 1 article reviews
primary antibodies against myod, myogenin, yap, p-yap, taz, tead1, cyclin d1, p53, p21, and gapdh - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
primary antibodies against cdk4, cdk6, cyclin d1, e2f1, rb, p-rb, cleaved caspase-3, and gapdh  (Cell Signaling Technology Inc)
90
Cell Signaling Technology Inc primary antibodies against cdk4, cdk6, cyclin d1, e2f1, rb, p-rb, cleaved caspase-3, and gapdh
Rosmarinic acid inhibits the expressions of cell proliferative genes. A: HT29 and SW480 cells were incubated with increasing concentrations of rosmarinic acid (RA) for 24 hours, followed by Western blot analysis <t>using</t> <t>antibodies</t> against cyclin D1 and MYC. α-Tublin was used as a loading control; B and C: The above cells were also prepared for quantitative real-time polymerase chain reaction to evaluate the mRNA levels of cyclin A1. <t>GAPDH</t> was used as an internal control; D: HT29 cells were treated with indicated concentrations of RA for 24 hours, followed by Western blot analysis using antibodies against Bcl-2, caspase-3, and GAPDH; E: HT29 cells were treated with indicated concentrations of RA for 24 hours, and then stained with Annexin V-FITC and propidium iodide. Percentages of Annexin V + cells are indicated in the scatterplot (right low and upper quadrants). n = 3. Data are shown as the mean ± SD. a P < 0.0001 vs group ‘0’. RA: Rosmarinic acid; AKT: Protein kinase B.
Primary Antibodies Against Cdk4, Cdk6, Cyclin D1, E2f1, Rb, P Rb, Cleaved Caspase 3, And Gapdh, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary antibodies against cdk4, cdk6, cyclin d1, e2f1, rb, p-rb, cleaved caspase-3, and gapdh/product/Cell Signaling Technology Inc
Average 90 stars, based on 1 article reviews
primary antibodies against cdk4, cdk6, cyclin d1, e2f1, rb, p-rb, cleaved caspase-3, and gapdh - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
primary antibodies against ccnd1  (Proteintech)
96
Proteintech primary antibodies against ccnd1
Rosmarinic acid inhibits the expressions of cell proliferative genes. A: HT29 and SW480 cells were incubated with increasing concentrations of rosmarinic acid (RA) for 24 hours, followed by Western blot analysis <t>using</t> <t>antibodies</t> against cyclin D1 and MYC. α-Tublin was used as a loading control; B and C: The above cells were also prepared for quantitative real-time polymerase chain reaction to evaluate the mRNA levels of cyclin A1. <t>GAPDH</t> was used as an internal control; D: HT29 cells were treated with indicated concentrations of RA for 24 hours, followed by Western blot analysis using antibodies against Bcl-2, caspase-3, and GAPDH; E: HT29 cells were treated with indicated concentrations of RA for 24 hours, and then stained with Annexin V-FITC and propidium iodide. Percentages of Annexin V + cells are indicated in the scatterplot (right low and upper quadrants). n = 3. Data are shown as the mean ± SD. a P < 0.0001 vs group ‘0’. RA: Rosmarinic acid; AKT: Protein kinase B.
Primary Antibodies Against Ccnd1, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary antibodies against ccnd1/product/Proteintech
Average 96 stars, based on 1 article reviews
primary antibodies against ccnd1 - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier

Image Search Results


Rosmarinic acid inhibits the expressions of cell proliferative genes. A: HT29 and SW480 cells were incubated with increasing concentrations of rosmarinic acid (RA) for 24 hours, followed by Western blot analysis using antibodies against cyclin D1 and MYC. α-Tublin was used as a loading control; B and C: The above cells were also prepared for quantitative real-time polymerase chain reaction to evaluate the mRNA levels of cyclin A1. GAPDH was used as an internal control; D: HT29 cells were treated with indicated concentrations of RA for 24 hours, followed by Western blot analysis using antibodies against Bcl-2, caspase-3, and GAPDH; E: HT29 cells were treated with indicated concentrations of RA for 24 hours, and then stained with Annexin V-FITC and propidium iodide. Percentages of Annexin V + cells are indicated in the scatterplot (right low and upper quadrants). n = 3. Data are shown as the mean ± SD. a P < 0.0001 vs group ‘0’. RA: Rosmarinic acid; AKT: Protein kinase B.

Journal: World Journal of Clinical Oncology

Article Title: Natural compound rosmarinic acid displays anti-tumor activity in colorectal cancer cells by suppressing nuclear factor-kappa B signaling

doi: 10.5306/wjco.v16.i5.105341

Figure Lengend Snippet: Rosmarinic acid inhibits the expressions of cell proliferative genes. A: HT29 and SW480 cells were incubated with increasing concentrations of rosmarinic acid (RA) for 24 hours, followed by Western blot analysis using antibodies against cyclin D1 and MYC. α-Tublin was used as a loading control; B and C: The above cells were also prepared for quantitative real-time polymerase chain reaction to evaluate the mRNA levels of cyclin A1. GAPDH was used as an internal control; D: HT29 cells were treated with indicated concentrations of RA for 24 hours, followed by Western blot analysis using antibodies against Bcl-2, caspase-3, and GAPDH; E: HT29 cells were treated with indicated concentrations of RA for 24 hours, and then stained with Annexin V-FITC and propidium iodide. Percentages of Annexin V + cells are indicated in the scatterplot (right low and upper quadrants). n = 3. Data are shown as the mean ± SD. a P < 0.0001 vs group ‘0’. RA: Rosmarinic acid; AKT: Protein kinase B.

Article Snippet: The primary antibodies against cyclin D1, MYC, α-Tublin, and GAPDH were purchased from Selleck, Houston, TX, United States.

Techniques: Incubation, Western Blot, Control, Real-time Polymerase Chain Reaction, Staining

Rosmarinic acid inhibits nuclear factor-kappa B signaling in colorectal cancer cells. A: Molecular modeling of rosmarinic acid (RA)/inhibitory kappa B kinase beta complex. 3D presentation of the molecular docking complex pose (I), 2D presentation (II), and 3D presentation (III) of the interactions between RA and the key residues of inhibitory kappa B kinase beta; B and C: HT29 (B) and SW480 (C) cells transfected with p-nuclear factor-kappa B-Luc along with Renilla luciferase were incubated with indicated RA overnight, followed by luciferase assay; D: HT29 and SW480 cells were incubated with increasing concentrations of RA for 24 hours, followed by Western blot analysis using antibodies against p-p65 and nuclear factor-kappa B P65. GAPDH was used as a loading control; E: Starved HT29 cells were treated with indicated RA for 12 hours, and then cells were incubated with 200 ng/mL lipopolysaccharide for 30 minutes, followed by Western blot analysis using antibodies against p-p65 and GAPDH; F and G: HT29 cells were incubated with increasing concentrations of RA for 24 hours, followed by quantitative real-time polymerase chain reaction to evaluate the mRNA levels of cyclin D1 (F) and MYC (G). GAPDH was used as an internal control. n = 3. Data are shown as the mean ± SD. a P < 0.001 vs group ‘0’, b P < 0.0001 vs group ‘0’. RA: Rosmarinic acid; NF-κB: Nuclear factor-kappa B; LPS: Lipopolysaccharide.

Journal: World Journal of Clinical Oncology

Article Title: Natural compound rosmarinic acid displays anti-tumor activity in colorectal cancer cells by suppressing nuclear factor-kappa B signaling

doi: 10.5306/wjco.v16.i5.105341

Figure Lengend Snippet: Rosmarinic acid inhibits nuclear factor-kappa B signaling in colorectal cancer cells. A: Molecular modeling of rosmarinic acid (RA)/inhibitory kappa B kinase beta complex. 3D presentation of the molecular docking complex pose (I), 2D presentation (II), and 3D presentation (III) of the interactions between RA and the key residues of inhibitory kappa B kinase beta; B and C: HT29 (B) and SW480 (C) cells transfected with p-nuclear factor-kappa B-Luc along with Renilla luciferase were incubated with indicated RA overnight, followed by luciferase assay; D: HT29 and SW480 cells were incubated with increasing concentrations of RA for 24 hours, followed by Western blot analysis using antibodies against p-p65 and nuclear factor-kappa B P65. GAPDH was used as a loading control; E: Starved HT29 cells were treated with indicated RA for 12 hours, and then cells were incubated with 200 ng/mL lipopolysaccharide for 30 minutes, followed by Western blot analysis using antibodies against p-p65 and GAPDH; F and G: HT29 cells were incubated with increasing concentrations of RA for 24 hours, followed by quantitative real-time polymerase chain reaction to evaluate the mRNA levels of cyclin D1 (F) and MYC (G). GAPDH was used as an internal control. n = 3. Data are shown as the mean ± SD. a P < 0.001 vs group ‘0’, b P < 0.0001 vs group ‘0’. RA: Rosmarinic acid; NF-κB: Nuclear factor-kappa B; LPS: Lipopolysaccharide.

Article Snippet: The primary antibodies against cyclin D1, MYC, α-Tublin, and GAPDH were purchased from Selleck, Houston, TX, United States.

Techniques: Transfection, Luciferase, Incubation, Western Blot, Control, Real-time Polymerase Chain Reaction